Cargando…
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
The commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. We genotyped 64 PanNETs and found 58% carry ATRX, DAXX, and MEN1 mutations (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all thr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185985/ https://www.ncbi.nlm.nih.gov/pubmed/30315258 http://dx.doi.org/10.1038/s41467-018-06498-2 |
_version_ | 1783362784599212032 |
---|---|
author | Chan, Chang S. Laddha, Saurabh V. Lewis, Peter W. Koletsky, Matthew S. Robzyk, Kenneth Da Silva, Edaise Torres, Paula J. Untch, Brian R. Li, Janet Bose, Promita Chan, Timothy A. Klimstra, David S. Allis, C. David Tang, Laura H. |
author_facet | Chan, Chang S. Laddha, Saurabh V. Lewis, Peter W. Koletsky, Matthew S. Robzyk, Kenneth Da Silva, Edaise Torres, Paula J. Untch, Brian R. Li, Janet Bose, Promita Chan, Timothy A. Klimstra, David S. Allis, C. David Tang, Laura H. |
author_sort | Chan, Chang S. |
collection | PubMed |
description | The commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. We genotyped 64 PanNETs and found 58% carry ATRX, DAXX, and MEN1 mutations (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all three genes (A-D-M WT PanNETs). We performed RNA sequencing and DNA-methylation analysis to reveal two distinct subgroups with one consisting entirely of A-D-M mutant PanNETs. Two genes differentiating A-D-M mutant from A-D-M WT PanNETs were high ARX and low PDX1 gene expression with PDX1 promoter hyper-methylation in the A-D-M mutant PanNETs. Moreover, A-D-M mutant PanNETs had a gene expression signature related to that of alpha-cells (FDR q-value < 0.009) of pancreatic islets including increased expression of HNF1A and its transcriptional target genes. This gene expression profile suggests that A-D-M mutant PanNETs originate from or transdifferentiate into a distinct cell type similar to alpha cells. |
format | Online Article Text |
id | pubmed-6185985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61859852018-10-15 ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup Chan, Chang S. Laddha, Saurabh V. Lewis, Peter W. Koletsky, Matthew S. Robzyk, Kenneth Da Silva, Edaise Torres, Paula J. Untch, Brian R. Li, Janet Bose, Promita Chan, Timothy A. Klimstra, David S. Allis, C. David Tang, Laura H. Nat Commun Article The commonly mutated genes in pancreatic neuroendocrine tumors (PanNETs) are ATRX, DAXX, and MEN1. We genotyped 64 PanNETs and found 58% carry ATRX, DAXX, and MEN1 mutations (A-D-M mutant PanNETs) and this correlates with a worse clinical outcome than tumors carrying the wild-type alleles of all three genes (A-D-M WT PanNETs). We performed RNA sequencing and DNA-methylation analysis to reveal two distinct subgroups with one consisting entirely of A-D-M mutant PanNETs. Two genes differentiating A-D-M mutant from A-D-M WT PanNETs were high ARX and low PDX1 gene expression with PDX1 promoter hyper-methylation in the A-D-M mutant PanNETs. Moreover, A-D-M mutant PanNETs had a gene expression signature related to that of alpha-cells (FDR q-value < 0.009) of pancreatic islets including increased expression of HNF1A and its transcriptional target genes. This gene expression profile suggests that A-D-M mutant PanNETs originate from or transdifferentiate into a distinct cell type similar to alpha cells. Nature Publishing Group UK 2018-10-12 /pmc/articles/PMC6185985/ /pubmed/30315258 http://dx.doi.org/10.1038/s41467-018-06498-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Chan, Chang S. Laddha, Saurabh V. Lewis, Peter W. Koletsky, Matthew S. Robzyk, Kenneth Da Silva, Edaise Torres, Paula J. Untch, Brian R. Li, Janet Bose, Promita Chan, Timothy A. Klimstra, David S. Allis, C. David Tang, Laura H. ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title | ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_full | ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_fullStr | ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_full_unstemmed | ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_short | ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
title_sort | atrx, daxx or men1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185985/ https://www.ncbi.nlm.nih.gov/pubmed/30315258 http://dx.doi.org/10.1038/s41467-018-06498-2 |
work_keys_str_mv | AT chanchangs atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT laddhasaurabhv atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT lewispeterw atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT koletskymatthews atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT robzykkenneth atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT dasilvaedaise atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT torrespaulaj atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT untchbrianr atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT lijanet atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT bosepromita atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT chantimothya atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT klimstradavids atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT alliscdavid atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup AT tanglaurah atrxdaxxormen1mutantpancreaticneuroendocrinetumorsareadistinctalphacellsignaturesubgroup |